250 related articles for article (PubMed ID: 10482146)
21. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
[TBL] [Abstract][Full Text] [Related]
22. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
Schleinitz MD; Olkin I; Heidenreich PA
Am Heart J; 2004 Dec; 148(6):990-7. PubMed ID: 15632883
[TBL] [Abstract][Full Text] [Related]
23. Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report.
Patel TN; Kreindel M; Lincoff AM
J Invasive Cardiol; 2006 Jul; 18(7):E211-3. PubMed ID: 16816452
[TBL] [Abstract][Full Text] [Related]
24. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Lin GM; Chu KM; Han CL
Am Heart J; 2010 Sep; 160(3):e21; author reply e23. PubMed ID: 20826238
[No Abstract] [Full Text] [Related]
25. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.
Sangiorgi GM; Morice MC; Bramucci E; Ferlini M; Grinfeld L; Petronio AS; Pierli C; Iadanza A; Biondi-Zoccai G; Colombo A
EuroIntervention; 2011 Nov; 7(7):813-9. PubMed ID: 22082577
[TBL] [Abstract][Full Text] [Related]
27. Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS; Jeong YH; Park Y; Park KS; Yun SE; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
JACC Cardiovasc Interv; 2011 Apr; 4(4):381-91. PubMed ID: 21511217
[TBL] [Abstract][Full Text] [Related]
28. Comparative inhibitory effects of cilostazol and ticlopidine on subacute stent thrombosis and platelet function in acute myocardial infarction patients with percutaneous coronary intervention.
Kawata M; Kuramoto E; Kataoka T; Saito A; Adachi K; Matsuura A; Sakamoto S
Int Heart J; 2005 Jan; 46(1):13-22. PubMed ID: 15858933
[TBL] [Abstract][Full Text] [Related]
29. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
Schömig A; Neumann FJ; Walter H; Schühlen H; Hadamitzky M; Zitzmann-Roth EM; Dirschinger J; Hausleiter J; Blasini R; Schmitt C; Alt E; Kastrati A
J Am Coll Cardiol; 1997 Jan; 29(1):28-34. PubMed ID: 8996291
[TBL] [Abstract][Full Text] [Related]
30. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
31. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
Müller C; Büttner HJ; Petersen J; Roskamm H
Circulation; 2000 Feb; 101(6):590-3. PubMed ID: 10673248
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.
Jauhar R; Bergman G; Savino S; Deutsch E; Shaknovich A; Parikh M; Sanborn TA
Am J Cardiol; 1999 Sep; 84(6):726-8, A8. PubMed ID: 10498144
[TBL] [Abstract][Full Text] [Related]
33. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
[No Abstract] [Full Text] [Related]
34. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
Sakurai R; Koo BK; Kaneda H; Bonneau HN; Nagai R
Int J Cardiol; 2013 Sep; 167(5):2250-8. PubMed ID: 22727963
[TBL] [Abstract][Full Text] [Related]
35. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS.
Tsuchikane E; Takeda Y; Nasu K; Awata N; Kobayashi T
Catheter Cardiovasc Interv; 2004 Sep; 63(1):44-51. PubMed ID: 15343566
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
[TBL] [Abstract][Full Text] [Related]
37. Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
Park SJ; Park DW; Kim YH; Kang SJ; Lee SW; Lee CW; Han KH; Park SW; Yun SC; Lee SG; Rha SW; Seong IW; Jeong MH; Hur SH; Lee NH; Yoon J; Yang JY; Lee BK; Choi YJ; Chung WS; Lim DS; Cheong SS; Kim KS; Chae JK; Nah DY; Jeon DS; Seung KB; Jang JS; Park HS; Lee K
N Engl J Med; 2010 Apr; 362(15):1374-82. PubMed ID: 20231231
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with clopidogrel and aspirin after coronary stenting.
Kolansky DM; Klugherz BD; Curran SC; Herrmann HC; Magness K; Wilensky RL; Hirshfeld JW
Catheter Cardiovasc Interv; 2000 Jul; 50(3):276-9. PubMed ID: 10878621
[TBL] [Abstract][Full Text] [Related]
39. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
[TBL] [Abstract][Full Text] [Related]
40. Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease.
Youn YJ; Lee JW; Ahn SG; Lee SH; Choi H; Yu CW; Hong YJ; Kwon HM; Hong MK; Jang Y; Yoon J
Am Heart J; 2014 Feb; 167(2):241-248.e1. PubMed ID: 24439986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
